NCT04171349View on ClinicalTrials.gov

Articaine vs Dexmedetomidine Supplemented Articaine

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

October 1, 2019

Study Completion Date

November 1, 2019

Conditions
Renal Failure
Interventions
DRUG

Articaine

Vial

DRUG

Dexmedetomidine

Vial

Trial Locations (1)

Unknown

Ain Shams University hosptal, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT04171349 - Articaine vs Dexmedetomidine Supplemented Articaine | Biotech Hunter | Biotech Hunter